about
Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysisA cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countriesA cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale.CARRS Surveillance study: design and methods to assess burdens from multiple perspectivesThe scope of cell phones in diabetes management in developing country health care settings.Physicochemical equivalence of generic antihypertensive medicines (EQUIMEDS): protocol for a quality of medicines assessmentPrevalence and incidence of hypertension: Results from a representative cohort of over 16,000 adults in three cities of South Asia.Technology for Diagnosis, Treatment, and Prevention of Cardiometabolic Disease in India.Protocol for the mWellcare trial: a multicentre, cluster randomised, 12-month, controlled trial to compare the effectiveness of mWellcare, an mHealth system for an integrated management of patients with hypertension and diabetes, versus enhanced usuPark availability and major depression in individuals with chronic conditions: Is there an association in urban India?Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial.Health-related quality of life variations by sociodemographic factors and chronic conditions in three metropolitan cities of South Asia: the CARRS study.The Development of mWellcare, an mHealth System for the Integrated Management of Hypertension and Diabetes in Primary Care.Multimorbidity in South Asian adults: prevalence, risk factors and mortality.Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis.Role of Mobile Phone Technology in Tobacco Cessation InterventionsDevelopment of mWellcare: an mHealth intervention for integrated management of hypertension and diabetes in low-resource settingsm-Power Heart Project - a nurse care coordinator led, mHealth enabled intervention to improve the management of hypertension in India: study protocol for a cluster randomized trialStrategic Opportunities for Leveraging Low-cost, High-impact Technological Innovations to Promote Cardiovascular Health in IndiaCardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populationsEffectiveness and cost-effectiveness of a Yoga-based Cardiac Rehabilitation (Yoga-CaRe) program following acute myocardial infarction: Study rationale and design of a multi-center randomized controlled trialAcceptability of a decision-support electronic health record system and its impact on diabetes care goals in South Asia: a mixed-methods evaluation of the CARRS trialDevelopment of a Yoga-Based Cardiac Rehabilitation (Yoga-CaRe) Programme for Secondary Prevention of Myocardial Infarction.Association between socioeconomic position and cardiovascular disease risk factors in rural north India: The Solan Surveillance StudyStrategies for Stakeholder Engagement and Uptake of New Intervention: Experience From State-Wide Implementation of mHealth Technology for NCD Care in Tripura, IndiaResponse by Prabhakaran et al to Letter Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial"Integrated Public Health and Health Service Delivery for Noncommunicable Diseases and Comorbid Infectious Diseases and Mental Health
P50
Q27316535-D61CD864-3827-43E3-A18B-F472EF4DD7C9Q28743646-41FC3C8F-400D-4B5C-9DA7-1656890C9F68Q34268450-9974D919-262B-4B5F-91DA-9B34F531E600Q34396399-B6B9AF60-60ED-43CF-8670-7D5B6F991AD9Q35337792-15848434-DAAB-4A8D-8E11-8A892DA92923Q37659754-03ACDC1D-F70D-42B2-8EEE-0D47A8BDF9DAQ38617671-2085B48B-0558-40AB-B992-19AE7B162494Q38760932-217CA9DB-A4FB-4D33-ACAC-3F06BC26D611Q39105733-2DD3428F-0158-49CF-BF38-B35702B2751DQ39279375-8C0403C2-A8B3-4A1F-99A9-6BBCFA7FF2E8Q40388489-F1AB3675-FCDF-43C6-8EBD-B0D9BBBCDDE9Q42650055-D1E435DB-B847-4EDD-9F0A-DAFCB6C8DA76Q47665046-00057EF0-87EF-4C25-80F9-68C2BF56867DQ50098895-6E1BC3A7-72C4-400D-87F0-D661D3E661F0Q52678845-230DF62B-A1E6-4597-A3AF-2D66118D549AQ57252722-CC3A6CDE-FDA1-4999-A798-633AC767D493Q58694716-BAD9E543-56BE-4A2A-9299-03F12AB37DF3Q58797673-AB632213-655A-4DB5-AAA2-52A437BB022BQ62488912-6B4A2B6E-4ACC-48DF-B03F-059FC046DE18Q63479407-BF8526AD-E4F6-4C5F-AFDF-DF44601E742CQ64132139-B33E819B-934E-466B-AE11-2CFE1814FB94Q64136590-BCD76028-576C-4A24-A6F6-04765C56B2CBQ64882639-2D8F2AAB-4755-4C27-88E0-56C559E59688Q91709800-1ACD95D4-DAA2-4CB0-9682-CB1770FA62F8Q92031338-EF5457FE-CC2F-46ED-BFDA-3698D40B2DD1Q92630011-9999803E-E10C-44BB-A4CB-BE09B60EF866Q95597296-87AAC537-AA19-4560-AC16-6C967E2C1E2E
P50
description
investigador
@es
researcher
@en
name
V S Ajay
@en
type
label
V S Ajay
@en
prefLabel
V S Ajay
@en
P31
P496
0000-0002-4102-0505